Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Lipoproteins lipase

Lipoprotein lipase (from bovine skimmed milk) [9004-02-8] [EC 3.1.1.34]. Purified by affinity chromatography on heparin-Sepharose [Shirai et al. Biochim Biophys Acta 665 504 1981]. [Pg.546]

Lipoproteins in Circulation Are Progressively Degraded by Lipoprotein Lipase... [Pg.842]

Gene activated Lipoprotein lipase fatty acid transporter protein adipocyte fatty acid binding protein acyl-CoA synthetase malic enzyme GLUT-4 glucose transporter phosphoenolpyruvate carboxykinase... [Pg.121]

Increased lipid synthesis/inhibi-tion of lipolysis Activation of lipoprotein lipase (LPL)/induc-tion of fatty acid synthase (FAS)/inactivation of hormone sensitive lipase (HSL) Facilitated uptake of fatty acids by LPL-dependent hydrolysis of triacylglycerol from circulating lipoproteins. Increased lipid synthesis through Akt-mediated FAS-expression. Inhibition of lipolysis by preventing cAMP-dependent activation of HSL (insulin-dependent activation of phosphodiesterases )... [Pg.634]

Figure 15-6. Transport and fate of major lipid substrates and metabolites. (FFA, free fatty acids LPL, lipoprotein lipase MG, monoacylglycerol TG, triacylglycerol VLDL, very low density lipoprotein.)... Figure 15-6. Transport and fate of major lipid substrates and metabolites. (FFA, free fatty acids LPL, lipoprotein lipase MG, monoacylglycerol TG, triacylglycerol VLDL, very low density lipoprotein.)...
The Action of Lipoprotein Lipase Forms Remnant Lipoproteins... [Pg.208]

Reaction with lipoprotein lipase results in the loss of approximately 90% of the triacylglycerol of chylomicrons and in the loss of apo C (which remrns to HDL) but not apo E, which is retained. The resulting chy-lotnicron remnant is about half the diameter of the parent chylomicron and is relatively enriched in cholesterol and cholesteryl esters because of the loss of triacylglycerol (Figure 25-3). Similar changes occur to VLDL, with the formation of VLDL remnants or IDL (intermediate-density lipoprotein) (Figure 25-4). [Pg.208]

HDL concentrations vary reciprocally with plasma triacylglycerol concentrations and directly with the activity of lipoprotein lipase. This may be due to surplus surface constituents, eg, phospholipid and apo A-I being released during hydrolysis of chylomicrons and VLDL and contributing toward the formation of preP-HDL and discoidal HDL. HDLj concentrations are inversely related to the incidence of coronary atherosclerosis, possibly because they reflect the efficiency of reverse cholesterol transport. HDL, (HDLj) is found in... [Pg.210]

Figure 25-5. Metabolism of high-density lipoprotein (HDL) in reverse cholesteroi transport. (LCAT, lecithinxholesterol acyltransferase C, cholesterol CE, cholesteryl ester PL, phospholipid A-l, apolipoprotein A-l SR-Bl, scavenger receptor B1 ABC-1, ATP binding cassette transporter 1.) Prep-HDL, HDLj, HDL3—see Table 25-1. Surplus surface constituents from the action of lipoprotein lipase on chylomicrons and VLDL are another source of preP-HDL. Hepatic lipase activity is increased by androgens and decreased by estrogens, which may account for higher concentrations of plasma HDLj in women. Figure 25-5. Metabolism of high-density lipoprotein (HDL) in reverse cholesteroi transport. (LCAT, lecithinxholesterol acyltransferase C, cholesterol CE, cholesteryl ester PL, phospholipid A-l, apolipoprotein A-l SR-Bl, scavenger receptor B1 ABC-1, ATP binding cassette transporter 1.) Prep-HDL, HDLj, HDL3—see Table 25-1. Surplus surface constituents from the action of lipoprotein lipase on chylomicrons and VLDL are another source of preP-HDL. Hepatic lipase activity is increased by androgens and decreased by estrogens, which may account for higher concentrations of plasma HDLj in women.
Goldberg IJ, Merkel M Lipoprotein lipase physiology, biochemistry and molecular biology. Front Biosci 2001 6 D388. [Pg.218]

Figure 27-1. Metabolic interrelationships between adipose tissue, the liver, and extrahepatic tissues. In extrahepatic tissues such as heart, metabolic fuels are oxidized in the following order of preference (1) ketone bodies, (2) fatty acids, (3) glucose. (LPL, lipoprotein lipase FFA, free fatty acids VLDL, very low density lipoproteins.)... Figure 27-1. Metabolic interrelationships between adipose tissue, the liver, and extrahepatic tissues. In extrahepatic tissues such as heart, metabolic fuels are oxidized in the following order of preference (1) ketone bodies, (2) fatty acids, (3) glucose. (LPL, lipoprotein lipase FFA, free fatty acids VLDL, very low density lipoproteins.)...
In adipose tissue, the effect of the decrease in insulin and increase in glucagon results in inhibition of lipo-genesis, inactivation of lipoprotein lipase, and activation of hormone-sensitive lipase (Chapter 25). This leads to release of increased amounts of glycerol (a substrate for gluconeogenesis in the liver) and free fatty acids, which are used by skeletal muscle and liver as their preferred metabolic fuels, so sparing glucose. [Pg.234]

Heart Pumping of blood Aerobic pathways, eg, P-oxidation and citric acid cycle Free fatty acids, lactate, ketone bodies, VLDL and chylomicron triacylglycerol, some glucose Lipoprotein lipase. Respiratory chain well developed. [Pg.235]

Adipose tissue Storage and breakdown of triacylglyc-erol Esterification of fatty acids and lipolysis lipogenesis Glucose, lipoprotein triacylglycerol Free fatty acids, glycerol Lipoprotein lipase, hormone-sensitive lipase... [Pg.235]

Heparin is an important anticoagulant. It binds with factors IX and XI, but its most important interaction is with plasma antithrombin III (discussed in Chapter 51). Heparin can also bind specifically to lipoprotein lipase present in capillary walls, causing a release of this enzyme into the circulation. [Pg.547]

Sample Collection and Enzyme Stability. Serum samples are collected with chemically clean, sterile glassware. Blood is allowed to clot at room temperature, the clot is gently separated from the test tube with an applicator stick, and the blood is centrifuged for 10 minutes at 1,000 g. If the red cells are known to contain the enzymes whose activity is being measured, as in the case of LD, even slightly hemolyzed serums must be discarded. When acid phosphatase is to be measured, the serum should be placed immediately in ice and processed as soon as possible, or it should be acidified by the addition of a small amount of sodium citrate. Anticoagulants such as EDTA, fluoride and oxalate inhibit some serum enzymes. However, heparin activates serum lipoprotein lipase. [Pg.190]

FIGURE 3.2.2 Metabolic pathways of carotenoids such as p-carotene. CM = chylomicrons. VLDL = very low-density lipoproteins. LDL = low-density lipoproteins. HDL = high-density lipoproteins. BCO = p-carotene 15,15 -oxygenase. BCO2 = p-carotene 9, 10 -oxygenase. LPL = lipoprotein lipase. RBP = retinol binding protein. SR-BI = scavenger receptor class B, type I. [Pg.162]

Both intact carotenoids and their apolar metabolites (retinyl esters) are secreted into the lymphatic system associated with CMs. In the blood circulation, CM particles undergo lipolysis, catalyzed by a lipoprotein lipase, resulting in the formation of CM remnants that are quickly taken up by the liver. In the liver, the remnant-associated carotenoid can be either (1) metabolized into vitamin A and other metabolites, (2) stored, (3) secreted with the bile, or (4) repackaged and released with VLDL particles. In the bloodstream, VLDLs are transformed to LDLs, and then HDLs by delipidation and the carotenoids associated with the lipoprotein particles are finally distributed to extrahepatic tissues (Figure 3.2.2). Time-course studies focusing on carotenoid appearances in different lipoprotein fractions after ingestion showed that CM carotenoid levels peak early (4 to 8 hr) whereas LDL and HDL carotenoid levels reach peaks later (16 to 24 hr). [Pg.163]

FIGURE 9. Endogenous lipoprotein metabolism. In liver cells, cholesterol and triglycerides are packaged into VLDL particles and exported into blood where VLDL is converted to IDL. Intermediate-density lipoprotein can be either cleared by hepatic LDL receptors or further metabolized to LDL. LDL can be cleared by hepatic LDL receptors or can enter the arterial wall, contributing to atherosclerosis. Acetyl CoA, acetyl coenzyme A Apo, apolipoprotein C, cholesterol CE, cholesterol ester FA, fatty acid HL, hepatic lipase HMG CoA, 3-hydroxy-3-methyglutaryl coenzyme A IDL, intermediate-density lipoprotein LCAT, lecithin-cholesterol acyltransferase LDL, low-density lipoprotein LPL, lipoprotein lipase VLDL, very low-density lipoprotein. [Pg.178]

Intravenous lipid emulsion particles are hydrolyzed in the bloodstream by the enzyme lipoprotein lipase to release free fatty acids and glycerol. Free fatty acids then are be taken up into adipose tissue for storage (triglycerides), oxidized to energy in various tissues (e.g., skeletal muscle), or recycled in the liver to make lipoproteins. [Pg.1495]


See other pages where Lipoproteins lipase is mentioned: [Pg.569]    [Pg.845]    [Pg.39]    [Pg.228]    [Pg.495]    [Pg.502]    [Pg.696]    [Pg.696]    [Pg.709]    [Pg.942]    [Pg.943]    [Pg.1160]    [Pg.125]    [Pg.207]    [Pg.208]    [Pg.212]    [Pg.229]    [Pg.232]    [Pg.118]    [Pg.150]    [Pg.176]    [Pg.176]    [Pg.193]   
See also in sourсe #XX -- [ Pg.125 , Pg.126 , Pg.207 , Pg.209 , Pg.210 ]

See also in sourсe #XX -- [ Pg.176 , Pg.1495 ]

See also in sourсe #XX -- [ Pg.268 ]

See also in sourсe #XX -- [ Pg.253 ]

See also in sourсe #XX -- [ Pg.396 ]

See also in sourсe #XX -- [ Pg.129 , Pg.130 , Pg.142 , Pg.143 , Pg.357 ]

See also in sourсe #XX -- [ Pg.162 , Pg.163 , Pg.278 , Pg.279 ]

See also in sourсe #XX -- [ Pg.51 , Pg.124 ]

See also in sourсe #XX -- [ Pg.497 ]

See also in sourсe #XX -- [ Pg.85 , Pg.109 , Pg.361 ]

See also in sourсe #XX -- [ Pg.1184 ]

See also in sourсe #XX -- [ Pg.413 , Pg.470 ]

See also in sourсe #XX -- [ Pg.340 ]

See also in sourсe #XX -- [ Pg.177 ]

See also in sourсe #XX -- [ Pg.47 , Pg.481 , Pg.482 ]

See also in sourсe #XX -- [ Pg.365 ]

See also in sourсe #XX -- [ Pg.81 ]

See also in sourсe #XX -- [ Pg.36 ]

See also in sourсe #XX -- [ Pg.114 ]

See also in sourсe #XX -- [ Pg.114 ]

See also in sourсe #XX -- [ Pg.521 ]

See also in sourсe #XX -- [ Pg.183 , Pg.215 , Pg.334 , Pg.356 ]

See also in sourсe #XX -- [ Pg.114 ]

See also in sourсe #XX -- [ Pg.327 , Pg.384 , Pg.386 ]

See also in sourсe #XX -- [ Pg.39 , Pg.201 ]

See also in sourсe #XX -- [ Pg.6 , Pg.23 , Pg.25 , Pg.122 , Pg.139 , Pg.143 , Pg.145 , Pg.176 , Pg.180 , Pg.217 , Pg.232 , Pg.234 , Pg.243 , Pg.283 , Pg.293 ]

See also in sourсe #XX -- [ Pg.433 , Pg.470 ]

See also in sourсe #XX -- [ Pg.181 , Pg.193 ]

See also in sourсe #XX -- [ Pg.430 , Pg.2639 ]

See also in sourсe #XX -- [ Pg.320 , Pg.321 , Pg.322 , Pg.324 ]

See also in sourсe #XX -- [ Pg.141 ]

See also in sourсe #XX -- [ Pg.294 ]

See also in sourсe #XX -- [ Pg.552 ]

See also in sourсe #XX -- [ Pg.356 ]

See also in sourсe #XX -- [ Pg.309 ]

See also in sourсe #XX -- [ Pg.85 , Pg.109 , Pg.361 ]

See also in sourсe #XX -- [ Pg.201 ]

See also in sourсe #XX -- [ Pg.315 ]

See also in sourсe #XX -- [ Pg.368 , Pg.369 , Pg.370 , Pg.381 ]

See also in sourсe #XX -- [ Pg.8 , Pg.57 ]

See also in sourсe #XX -- [ Pg.2 , Pg.24 ]

See also in sourсe #XX -- [ Pg.690 ]

See also in sourсe #XX -- [ Pg.42 , Pg.350 ]

See also in sourсe #XX -- [ Pg.132 ]

See also in sourсe #XX -- [ Pg.539 ]

See also in sourсe #XX -- [ Pg.250 ]

See also in sourсe #XX -- [ Pg.46 , Pg.178 ]

See also in sourсe #XX -- [ Pg.158 ]

See also in sourсe #XX -- [ Pg.254 ]

See also in sourсe #XX -- [ Pg.141 ]

See also in sourсe #XX -- [ Pg.11 , Pg.13 , Pg.206 , Pg.215 , Pg.217 ]

See also in sourсe #XX -- [ Pg.4 ]

See also in sourсe #XX -- [ Pg.4 , Pg.67 , Pg.71 ]

See also in sourсe #XX -- [ Pg.146 , Pg.149 , Pg.150 , Pg.154 , Pg.202 , Pg.220 , Pg.222 , Pg.227 , Pg.313 ]




SEARCH



Adipose tissue lipoprotein lipase

Apoprotein lipoprotein lipase activation

Endothelial lipoprotein lipase

Enzymes lipoprotein lipase

Inhibitor, lipoprotein-lipase

Insulin lipoprotein lipase stimulation

Lipases lipoprotein lipase

Lipolysis lipoprotein lipase

Lipoprotein lipase activation

Lipoprotein lipase activity

Lipoprotein lipase activity, effect

Lipoprotein lipase and

Lipoprotein lipase apolipoproteins

Lipoprotein lipase deficiency

Lipoprotein lipase degradation

Lipoprotein lipase distribution

Lipoprotein lipase enzyme, activity

Lipoprotein lipase expression

Lipoprotein lipase familial deficiency

Lipoprotein lipase function

Lipoprotein lipase gene expression

Lipoprotein lipase immobilized

Lipoprotein lipase in adipose tissue

Lipoprotein lipase migration

Lipoprotein lipase properties

Lipoprotein lipase regulation

Lipoprotein lipase serum

Lipoprotein lipase stability

Lipoprotein lipase stimulation

Lipoprotein lipase synthesis

Lipoprotein lipase treatment

Lipoprotein lipase triacylglycerol, adipose tissue

Lipoprotein lipase, human

Lipoprotein lipases genetic deficiency

Lipoprotein lipases heparin binding

Lipoprotein lipases proteins

Lipoprotein lipases receptors

Lipoprotein lipases structure

Lipoprotein lipases transcription activation

Plasma lipoprotein lipase

Tissue lipoprotein lipase activity

© 2024 chempedia.info